Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Barron Von Hymen who wrote (1630)	12/17/1999 5:50:00 AM
From: Henry Niman	Respond to of 1722

These mergers should keep things interesting

To: Barron Von Hymen who wrote (1630)	12/17/1999 11:39:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 1722

Actually, Merger Mania by pharmas has been a very popular topic today on the financial networks 207.235.5.146

To: Barron Von Hymen who wrote (1630)	12/17/1999 11:37:00 PM
From: jeff greene	Respond to of 1722

BVH -- Dang! What happens to PFE after MTC and PNU merge and PFE doesn't get WLA? We're talking about cutting a good chunk of 2 blockbuster profits out of PFE's pockets? You might want to consider the chunk of revenues cut out of MTC and WLA if they lose the Pfizer marketing clout with both the drugs, Lipitor and Celebrex. With the competitive threat from Merck in both product categories, MTC and WLA/AHP would be eaten alive. As both MTC and WLA realize, even the disruption of the breakup of these relationships would take billions away from Lipitor and Celebrex short term and long term, before another joint partner could be brought up to speed in place of Pfizer. And as to Pfizer's organic growth, it only has 5 - billion dollar drugs in the camp; Zithromax,Diflucan,Viagra,Zoloft, and Norvasc with the next to be launched this year, Zeldox and possibly the migraine drug. Jeff